SEC Form 4 · accession 0000874015-16-000128
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Breaux Castleman
Director
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 1, 2016 | M | 469 | $0.00 | A | 3,950 | D | |
| Common StockF2 | Jul 1, 2016 | M | 667 | $0.00 | A | 4,617 | D | |
| Common StockF3 | Jul 1, 2016 | M | 937 | $0.00 | A | 5,554 | D | |
| Common StockF4 | Jul 1, 2016 | M | 667 | $0.00 | A | 6,221 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF5,F6 | — | Jul 1, 2016 | M | 2,740 | D | — | — | Common Stock | 2,740 | 4,738 | D |
| Restricted Stock UnitsF5,F7 | — | Jul 1, 2016 | A | 2,667 | A | — | — | Common Stock | 2,667 | 2,667 | D |
| Director Stock Option (right to buy)F8 | $24.42 | Jul 1, 2016 | A | 16,000 | A | Jul 1, 2017 | Jun 30, 2026 | Common Stock | 16,000 | 16,000 | D |
Explanation of responses
- F1Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on July 1, 2013.
- F2Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on July 1, 2015.
- F3Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on June 25, 2013.
- F4Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on July 1, 2014.
- F5Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- F6Restricted Stock Units vest in equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
- F7Grant of July 1, 2016 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2017. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2020. The RSU is vested as to 0 shares on July 1, 2016.
- F8Grant of July 1, 2016 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2017. The option shall be fully vested and exercisable on July 1, 2020. The option is exercisable as to 0 shares on July 1, 2016.